N'-[(5-Fluoro-2-hydroxy-3-propylphenyl)methylene]-4-(phenylmethyl)-1-piperazineacetohydrazide

ID: ALA3426436

Chembl Id: CHEMBL3426436

PubChem CID: 136934937

Max Phase: Preclinical

Molecular Formula: C23H29FN4O2

Molecular Weight: 412.51

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCCc1cc(F)cc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O

Standard InChI:  InChI=1S/C23H29FN4O2/c1-2-6-19-13-21(24)14-20(23(19)30)15-25-26-22(29)17-28-11-9-27(10-12-28)16-18-7-4-3-5-8-18/h3-5,7-8,13-15,30H,2,6,9-12,16-17H2,1H3,(H,26,29)/b25-15+

Standard InChI Key:  SGSXUIKYSRXQEC-MFKUBSTISA-N

Alternative Forms

1. Parent:

   

   ALA3426436

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 412.51

Molecular Weight (Monoisotopic): 412.2275

AlogP: 2.75

#Rotatable Bonds: 8

Polar Surface Area: 68.17

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 8.81

CX Basic pKa: 7.17

CX LogP: 3.69

CX LogD: 3.59

Aromatic Rings: 2

Heavy Atoms: 30

QED Weighted: 0.52

Np Likeness Score: -1.64

References

1. Roth HS, Botham RC, Schmid SC, Fan TM, Dirikolu L, Hergenrother PJ..  (2015)  Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics.,  58  (9): [PMID:25856364] [10.1021/acs.jmedchem.5b00413]

Source

Source(1):

• Scientific Literature